CAREDX, INC. Sale of Stock, Consideration Received on Transaction
CAREDX, INC. (CDNA) had Sale of Stock, Consideration Received on Transaction of $134.60 million as of 2020-06-15, per its 10-K filed 2022-02-24.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2022-02-24
- 2020-06-15: Sale of Stock, Consideration Received on Transaction $134.60M.
- 2013-07-31: Sale of Stock, Consideration Received on Transaction 1 month $467.00K.
| Period end | Sale of Stock, Consideration Received on Transaction | Sale of Stock, Consideration Received on Transaction 1 month |
|---|---|---|
| 2020-06-15 | $134.60M 10-K · filed 2022-02-24 | |
| 2013-07-31 | $467.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |